Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-14-088001
Filing Date
2014-12-22
Accepted
2014-12-19 18:31:19
Documents
3
Group Members
NOVARTIS AG

Document Format Files

Seq Description Document Type Size
1 SC 13G a14-26546_1sc13g.htm SC 13G 116356
2 GRAPHIC g265461bii001.gif GRAPHIC 247709
3 GRAPHIC g265461bii002.gif GRAPHIC 247560
  Complete submission text file 0001104659-14-088001.txt   800608
Mailing Address LICHTSTRASSE 35 CH-4002 BASEL V8
Business Address LICHTSTRASSE 35 CH-4002 BASEL V8 212-830-2474
NOVARTIS PHARMA AG (Filed by) CIK: 0001030617 (see all company filings)

Type: SC 13G

Mailing Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450
Business Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450 972-2-548-9100
BioLineRx Ltd. (Subject) CIK: 0001498403 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86614 | Film No.: 141301023
SIC: 2834 Pharmaceutical Preparations